匯友生命科學(08088.HK)接獲聯交所上市科信函 或暫停股份交易
格隆匯 11 月 9日丨匯友生命科學(08088.HK)發佈公告,公司已接獲聯交所上市科的信函,其表示對公司業務欠缺實質性、並不可行及可持續,且可能未能遵守聯交所GEM證券上市規則第17.26條的規定表示關注。聯交所尚未作出任何決定,惟聯交所可能根據GEM上市規則第9.04(3)條暫停公司股份買賣。
公司正在提交書面陳詞,説明公司已遵守GEM上市規則第17.26條,以及聯交所不應展開取消公司股份在聯交所GEM上市地位程序的因由及解釋。公司擬就此向聯交所提交進一步資料。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.